Target intelligence / Profile preview

Herpes simplex virus helicase-primase subunit UL8 (UL8)

Target
UL8
Molecular classification
Viral protein, Helicase-primase complex subunit, Accessory protein
01

Overview

The UL8 accessory subunit is an essential component of the Herpes Simplex Virus (HSV) heterotrimeric helicase-primase complex, which also includes the UL5 helicase and UL52 primase subunits (UniProt P10236). While UL8 lacks independent enzymatic activity, it plays a critical role in viral DNA replication by facilitating the nuclear import of the UL5/UL52 subcomplex and enhancing the efficiency of primer utilization during lagging-strand synthesis (PubMed: 11836371). It acts as a scaffold that coordinates the interaction between the helicase-primase complex and other replication proteins, such as the viral polymerase and the single-stranded DNA-binding protein ICP8 (PubMed: 15140983). Because the helicase-primase complex is vital for viral genome replication and has no direct human homolog, it is a highly validated therapeutic target. Drugs like Pritelivir and Amenamevir target this complex, offering a potent alternative to traditional nucleoside analogs by inhibiting the enzymatic activity and stabilizing the complex on DNA to stall replication (PubMed: 24350651).

Other names
UL8 accessory proteinHSV-1 UL8 proteinHelicase-primase complex subunit UL8UL8 subunit
02

Mechanism of action

Inhibition of the helicase-primase complex by stabilizing the complex on DNA, thereby preventing the progression of the replication fork and inhibiting viral DNA synthesis.

03

Biological functions

Viral DNA replicationProtein-protein interactionNuclear localization of the helicase-primase complexPrimer utilization enhancementLagging-strand synthesis coordination
04

Disease associations

Herpes simplex virus infectionHerpes labialisGenital herpesHerpetic keratitisHerpes simplex encephalitis
05

Safety considerations

Development of drug resistance (mutations in UL5 or UL52)Potential for off-target effects (though low due to viral specificity)Limited efficacy in latent infection
06

Interacting drugs

Amenamevir

3 more in the full profile.

07

Biomarkers

Viral load (HSV DNA levels)UL5/UL52/UL8 mutation status (for resistance monitoring)

Beyond the preview

Go deeper on Herpes simplex virus helicase-primase subunit UL8 (UL8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus helicase-primase subunit UL8 (UL8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call